- Home
- VGAS vs ICCM Comparison
VGAS vs ICCM Comparison
Compare VGAS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGAS
- ICCM
- Stock Information
- Founded
- VGAS 2007
- ICCM 2006
- Country
- VGAS United States
- ICCM Israel
- Employees
- VGAS N/A
- ICCM N/A
- Industry
- VGAS Major Chemicals
- ICCM
- Sector
- VGAS Industrials
- ICCM
- Exchange
- VGAS Nasdaq
- ICCM Nasdaq
- Market Cap
- VGAS 61.1M
- ICCM 61.1M
- IPO Year
- VGAS N/A
- ICCM N/A
- Fundamental
- Price
- VGAS $2.90
- ICCM $0.99
- Analyst Decision
- VGAS
- ICCM Strong Buy
- Analyst Count
- VGAS 0
- ICCM 1
- Target Price
- VGAS N/A
- ICCM $2.00
- AVG Volume (30 Days)
- VGAS 5.5K
- ICCM 1.9M
- Earning Date
- VGAS 11-12-2025
- ICCM 08-13-2025
- Dividend Yield
- VGAS N/A
- ICCM N/A
- EPS Growth
- VGAS N/A
- ICCM N/A
- EPS
- VGAS N/A
- ICCM N/A
- Revenue
- VGAS N/A
- ICCM $2,787,000.00
- Revenue This Year
- VGAS N/A
- ICCM $62.11
- Revenue Next Year
- VGAS N/A
- ICCM $142.91
- P/E Ratio
- VGAS N/A
- ICCM N/A
- Revenue Growth
- VGAS N/A
- ICCM N/A
- 52 Week Low
- VGAS $2.50
- ICCM $0.48
- 52 Week High
- VGAS $4.54
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- VGAS 49.10
- ICCM 49.14
- Support Level
- VGAS $2.78
- ICCM $0.98
- Resistance Level
- VGAS $3.21
- ICCM $1.12
- Average True Range (ATR)
- VGAS 0.20
- ICCM 0.07
- MACD
- VGAS 0.02
- ICCM -0.00
- Stochastic Oscillator
- VGAS 27.27
- ICCM 11.82
About VGAS Verde Clean Fuels Inc.
Verde Clean Fuels Inc is a renewable energy company specializing in the conversion of synthesis gas, or syngas, derived from diverse feedstocks, such as biomass, MSW, and mixed plastics, as well as natural gas (including synthetic natural gas) and other feedstocks, into liquid hydrocarbons that can be used as gasoline through a proprietary liquid fuels technology, the STG process.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.